Search - Role of intra-Clonal HEterogeneity and Leukemic environment in ThErapy Resistance of chronic leukemias Access content directly

Filter your results

42 Results
Deposit type : Notice

DNA Methylation and Intra-Clonal Heterogeneity: The Chronic Myeloid Leukemia Model

Benjamin Lebecque , Céline Bourgne , Véronique Vidal , Marc Berger
Cancers, 2021, 13 (14), pp.3587. ⟨10.3390/cancers13143587⟩
Journal articles hal-03440088v1

Characterization of the novel HLA‐DQA1 *01:39 allele by next‐generation sequencing

Steve Genebrier , Paul Rouzaire , Emeric Texeraud , Gerald Bertrand , Virginie Renac et al.
HLA: Immune Response Genetics, 2021, 98 (3), pp.240-241. ⟨10.1111/tan.14142⟩
Journal articles hal-03449390v1

Characterization of the novel HLA‐C *06:311 allele by sequencing‐based typing

Lucie Blandin , Mamy Ralazamahaleo , Marine Cargou , Richard Lemal , Paul Rouzaire et al.
HLA: Immune Response Genetics, 2021, 97 (6), pp.565-566. ⟨10.1111/tan.14233⟩
Journal articles hal-03449287v1

Double L611S/V617F JAK2 mutation in a child with erythrocytosis

Benjamin Lebecque , Victoria Grèze , Thomas Tassin , Gabrielle Mareynat , Louis‐thomas Dannus et al.
Pediatric Blood and Cancer, 2021, 68 (4), ⟨10.1002/pbc.28816⟩
Journal articles hal-03157939v1

Définition et standardisation des bilans d’histocompatibilité en fonction du parcours du patient et du type de donneur : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) et de la Société Francophone d’Histocompatibilité et Immunogénétique (SFHI)

Valérie Dubois , Kahina Amokrane , Roberto Crocchiolo , Marylise Fort , Nicolas Guillaume et al.
Bulletin du Cancer, 2021, ⟨10.1016/j.bulcan.2021.01.024⟩
Journal articles hal-03449096v1

Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study

Laetitia Largeaud , Pascale Cornillet-Lefebvre , Jean-François Hamel , Pierre-Yves Dumas , Naïs Prade et al.
Leukemia, 2021, 35 (5), pp.1291-1300. ⟨10.1038/s41375-020-01031-1⟩
Journal articles hal-03441014v1

Efficiency of nilotinib to target chronic phase-chronic myeloid leukaemia primary mature CD34− and immature CD34+ cells

Marc Berger , Benjamin Lebecque , Thomas Tassin , Louis-Thomas Dannus , Juliette Berger et al.
Scientific Reports, 2021, 11 (1), ⟨10.1038/s41598-021-85734-0⟩
Journal articles hal-03278034v1

Splenectomy before allogeneic hematopoietic cell transplantation for myelofibrosis: A French nationwide study

Jean‐baptiste Bossard , Jean‐baptiste Beuscart , Marie Robin , Mohamad Mohty , Fiorenza Barraco et al.
American Journal of Hematology, 2021, 96 (1), pp.80-88. ⟨10.1002/ajh.26034⟩
Journal articles hal-03089653v1

Characterization of the novel HLA‐B *56:76 allele by sequencing‐based typing

Lucie Blandin , Jonathan Visentin , Gwendaline Guidicelli , Paul Rouzaire , Richard Lemal et al.
HLA: Immune Response Genetics, 2021, 98 (1), pp.66-67. ⟨10.1111/tan.14237⟩
Journal articles hal-03449232v1

Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial

Anne Bouvier , Jean-Francois Hamel , Jacques Delaunay , Eric Delabesse , Pierre-Yves Dumas et al.
European Journal of Haematology, 2021, 107 (1), pp.111-121. ⟨10.1111/ejh.13626⟩
Journal articles hal-03604930v1

Characterization of the novel HLA‐DQA1 *05:01:07 allele by sequencing‐based typing

Lucie Blandin , Mamy Ralazamahaleo , Gwendaline Guidicelli , Paul Rouzaire , Richard Lemal et al.
HLA: Immune Response Genetics, 2021, ⟨10.1111/tan.14484⟩
Journal articles hal-03443769v1

Corrigendum to ‘Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers’

G. Fossard , F. Broussais , I. Coelho , S. Bailly , E. Nicolas-Virelizier et al.
Annals of Oncology, 2021, 32 (7), pp.945. ⟨10.1016/j.annonc.2021.04.021⟩
Journal articles hal-03440923v1

Droplet digital PCR allows vector copy number assessment and monitoring of experimental CAR T cells in murine xenograft models or approved CD19 CAR T cell-treated patients

Rafik Haderbache , Walid Warda , Eric Hervouet , Mathieu Neto da Rocha , Rim Trad et al.
Journal of Translational Medicine, 2021, 19 (1), ⟨10.1186/s12967-021-02925-z⟩
Journal articles hal-03443941v1

Characterization of the novel HLA‐C *05:01:58 allele by sequencing‐based typing

Lucie Blandin , Gwendaline Guidicelli , Laura Blouin , Richard Lemal , Paul Rouzaire et al.
HLA: Immune Response Genetics, 2021, 98 (2), pp.170-171. ⟨10.1111/tan.14303⟩
Journal articles hal-03449041v1

Characterization of the novel HLA‐B *14:01:13 allele by sequencing‐based typing

Lucie Blandin , Jonathan Visentin , Gwendaline Guidicelli , Richard Lemal , Paul Rouzaire et al.
HLA: Immune Response Genetics, 2021, 98 (2), pp.155-156. ⟨10.1111/tan.14304⟩
Journal articles hal-03449051v1

Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: Results of a prospective observational study

Olivier Tournilhac
Bone Marrow Transplantation, 2021, 56 (3), pp.692-695. ⟨10.1038/s41409-020-01013-y⟩
Journal articles hal-03737669v1

Correction to: Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: results of a prospective observational study

Johannes Schetelig , Jennifer Hoek , Stephan Stilgenbauer , Jan Moritz Middeke , Niels Smedegaard Andersen et al.
Bone Marrow Transplantation, 2021, ⟨10.1038/s41409-021-01524-2⟩
Journal articles hal-03440366v1

Single-Agent Ibrutinib for Rituximab-Refractory Waldenström Macroglobulinemia: Final Analysis of the Substudy of the Phase III Innovate TM Trial

Judith Trotman , Christian Buske , Alessandra Tedeschi , Jeffrey Matous , David Macdonald et al.
Clinical Cancer Research, 2021, 27 (21), pp.5793-5800. ⟨10.1158/1078-0432.CCR-21-1497⟩
Journal articles hal-03440467v1

Front-line chemo-immunotherapy is not inferior to ibrutinib in CLL

M. van Gelder , O. Tournilhac , D. Te Raa , H.P.J. Visser
Annals of Oncology, 2021, 32 (11), pp.1442-1443. ⟨10.1016/j.annonc.2021.08.1990⟩
Journal articles hal-03440402v1

No Detectable Alteration of Inorganic Allogeneic Bone Matrix Colonizing Mesenchymal Cells: A Step Towards Personalized Bone Grafts

Roger Erivan , Nicolas Samper , Guillaume Villatte , Stéphane Boisgard , Stéphane Descamps et al.
Journal of Bone Metabolism, 2021, 28 (2), pp.161-169. ⟨10.11005/jbm.2021.28.2.161⟩
Journal articles hal-03280648v1

Allogeneic hematopoietic stem cell transplantation from unmanipulated haploidentical donor and unrelated cord blood for T-cell lymphoma: a retrospective study from the Société Francophone de Greffe de Moelle et de Therapie Cellulaire

Jerome Cornillon , Elisabeth Daguenet , Olivier Tournilhac , Didier Blaise , Stephanie Nguyen et al.
Bone Marrow Transplantation, 2021, 56 (11), pp.2849-2856. ⟨10.1038/s41409-021-01426-3⟩
Journal articles hal-03440554v1

Efficacy of minimal residual disease driven immune-intervention after allogeneic hematopoietic stem cell transplantation for high-risk chronic lymphocytic leukemia: results of a prospective multicenter trial

Olivier Tournilhac , Magali Le Garff-Tavernier , Stéphanie Nguyen Quoc , Edouard Forcade , Patrice Chevallier et al.
Haematologica, 2021, 106 (7), pp.1867-1875. ⟨10.3324/haematol.2019.239566⟩
Journal articles hal-03440980v1

Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial

Gerald Wulf , Bettina Altmann , Marita Ziepert , Francesco D’amore , Gerhard Held et al.
Leukemia, 2021, 35 (1), pp.143-155. ⟨10.1038/s41375-020-0838-5⟩
Journal articles hal-03441040v1

Characterization of the novel HLA‐DQA1 *05:18 allele by next‐generation sequencing

Steve Genebrier , Paul Rouzaire , Emeric Texeraud , Gerald Bertrand , Virginie Renac et al.
HLA: Immune Response Genetics, 2021, 98 (5), pp.494-496. ⟨10.1111/tan.14202⟩
Journal articles hal-03449340v1

Characterization of the novel HLA‐A *26:01:66 allele by sequencing‐based typing

Lucie Blandin , Jonathan Visentin , Marine Cargou , Richard Lemal , Paul Rouzaire et al.
HLA: Immune Response Genetics, 2021, 97 (6), pp.532-533. ⟨10.1111/tan.14235⟩
Journal articles hal-03449261v1

Characterization of the novel HLA‐C *04:451 allele by sequencing‐based typing

Lucie Blandin , Jonathan Visentin , Mamy Ralazamahaleo , Richard Lemal , Paul Rouzaire et al.
HLA: Immune Response Genetics, 2021, 98 (5), pp.483-485. ⟨10.1111/tan.14384⟩
Journal articles hal-03443857v1

Correction to: Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party

Johannes Schetelig , Patrice Chevallier , Michel van Gelder , Jennifer Hoek , Olivier Hermine et al.
Bone Marrow Transplantation, 2021, ⟨10.1038/s41409-021-01516-2⟩
Journal articles hal-03440115v1

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis

Efstathios Kastritis , Giovanni Palladini , Monique Minnema , Ashutosh Wechalekar , Arnaud Jaccard et al.
New England Journal of Medicine, 2021, 385 (1), pp.46-58. ⟨10.1056/NEJMoa2028631⟩
Journal articles hal-03449529v1

Characterization of the novel HLA‐DQA1 *01:19 allele by next‐generation sequencing

Steve Genebrier , Paul Rouzaire , Carl Nivet , Mathilde Chérel , Virginie Renac et al.
HLA: Immune Response Genetics, 2021, 97 (3), pp.250-251. ⟨10.1111/tan.14129⟩
Journal articles hal-03449408v1

Characterization of the novel HLA‐DQA1 *01:01:10 allele by sequencing‐based typing

Lucie Blandin , Marine Cargou , Gwendaline Guidicelli , Paul Rouzaire , Richard Lemal et al.
HLA: Immune Response Genetics, 2021, 98 (4), pp.405-406. ⟨10.1111/tan.14307⟩
Journal articles hal-03444028v1